首页> 外文期刊>Cellular Physiology and Biochemistry >Autophagy and Ubiquitin-Mediated Proteolytic Degradation of PML/Rarα Fusion Protein in Matrine-Induced Differentiation Sensitivity Recovery of ATRA-Resistant APL (NB4-LR1) Cells: in Vitro and in Vivo Studies
【24h】

Autophagy and Ubiquitin-Mediated Proteolytic Degradation of PML/Rarα Fusion Protein in Matrine-Induced Differentiation Sensitivity Recovery of ATRA-Resistant APL (NB4-LR1) Cells: in Vitro and in Vivo Studies

机译:自噬和泛素介导的PML /Rarα融合蛋白在苦参碱诱导的ATRA耐药APL(NB4-LR1)细胞分化敏感性恢复中的蛋白水解降解:体内和体外研究

获取原文
           

摘要

Background/Aims Although the cure rate of acute promyelocytic leukemia (APL) has exceeded 90%, the relapse/refractory APL that resistant to all-trans retinoic acid (ATRA) or ATO was still serious concern. Matrine (MAT) could improve the differentiation ability of ATRA-resistant APL cells. This study aimed to explore how the APL-specific fusion protein was degraded in ATRA-resistant APL with the application of MAT and ATRA. Methods ATRA-sensitive (NB4) and ATRA-resistant (NB4-LR1) cell lines were used. Nitroblue tetrazolium reduction assay and flow cytometry were used to detect the differentiation ability. The activity of ubiquitin-proteasome and autophagy-mediated pathways in both cells treated with ATRA with or without MAT were compared in protein and mRNA level (Western blot analysis, qRT-PCR), the Fluorescent substrate Suc-LLVY-AMC detection was used to detect the activity of proteasome, and electron microscope for observing autophagosome. MG 132(proteasome inhibitor), rapamycin (autophagy activator), hydroxychloroquine (lysosomal inhibitor) and STI571 [retinoic acid receptor alpha (RARα) ubiquitin stabilizer] were used as positive controls. The effect of MAT was observed in vivo using xenografts. Results MAT improved the sensitivity of NB4-LR1cells to ATRA treatment, which was consistent with the expression of PML-RARα fusion protein. MAT promoted the ubiquitylation level in NB4-LR1. MG 132 induced the decrease in RARα in both cell lines, and hampered the differentiation of NB4 cells. MAT also promoted the autophagy in NB4-LR1 cells, with an increase in microtubule-associated protein 1 light chain3 (LC3)-II and LC3-II/LC3-I ratio and exhaustion of P62. The expression of LC3II increased significantly in the MAT and ATRA + MAT groups in combination with lysosomal inhibitors. A similar phenomenon was observed in mouse xenografts. MAT induced apoptosis and differentiation. Conclusions Autophagy and ubiquitin-mediated proteolytic degradation of PML/RARα fusion protein are crucial in MAT-induced differentiation sensitivity recovery of NB4-LR1 cells.
机译:背景/目的尽管急性早幼粒细胞白血病(APL)的治愈率已超过90%,但对全反式维甲酸(ATRA)或ATO耐药的复发/难治性APL仍是值得关注的问题。苦参碱(MAT)可以提高抗ATRA的APL细胞的分化能力。这项研究旨在探讨如何通过MAT和ATRA在ATRA耐药APL中降解APL特异性融合蛋白。方法使用ATRA敏感(NB4)和ATRA耐药(NB4-LR1)细胞系。使用硝基蓝四氮唑还原法和流式细胞仪检测其分化能力。比较蛋白和mRNA水平(蛋白质印迹和qRT-PCR),比较ATRA处理和不使用MAT处理的两种细胞中泛素-蛋白酶体和自噬介导的途径的活性(Western blot分析,qRT-PCR),使用荧光底物Suc-LLVY-AMC检测检测蛋白酶体的活性,并用电子显微镜观察自噬体。 MG 132(蛋白酶体抑制剂),雷帕霉素(自噬激活剂),羟氯喹(溶酶体抑制剂)和STI571(视黄酸受体α(RARα)泛素稳定剂)用作阳性对照。使用异种移植物在体内观察到MAT的作用。结果MAT提高了NB4-LR1细胞对ATRA治疗的敏感性,这与PML-RARα融合蛋白的表达一致。 MAT促进了NB4-LR1中的泛素化水平。 MG 132诱导了两种细胞系中RARα的降低,并阻碍了NB4细胞的分化。 MAT还促进了NB4-LR1细胞的自噬,并增加了微管相关蛋白1轻链3(LC3)-II和LC3-II / LC3-I的比例,并耗尽了P62。结合溶酶体抑制剂,MAT和ATRA + MAT组中LC3II的表达显着增加。在小鼠异种移植物中观察到类似现象。 MAT诱导细胞凋亡和分化。结论PML /RARα融合蛋白的自噬和泛素介导的蛋白水解降解在MAT诱导的NB4-LR1细胞分化敏感性恢复中至关重要。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号